Home - Products - Apoptosis - Apoptosis - 5-Benzylidene-3-ethyl rhodanine

5-Benzylidene-3-ethyl rhodanine

CAS No. 18331-34-5

5-Benzylidene-3-ethyl rhodanine ( —— )

Catalog No. M20405 CAS No. 18331-34-5

5-Benzylidene-3-ethyl rhodanine(BTR-1) is an active anti-cancer agent. BTR-1 activates apoptosis and induces cell death.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 71 In Stock
5MG 110 In Stock
10MG 177 In Stock
25MG 332 In Stock
50MG 478 In Stock
100MG 691 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5-Benzylidene-3-ethyl rhodanine
  • Note
    Research use only not for human use.
  • Brief Description
    5-Benzylidene-3-ethyl rhodanine(BTR-1) is an active anti-cancer agent. BTR-1 activates apoptosis and induces cell death.
  • Description
    5-Benzylidene-3-ethyl rhodanine(BTR-1) is an active anti-cancer agent. BTR-1 activates apoptosis and induces cell death.
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    18331-34-5
  • Formula Weight
    249.35
  • Molecular Formula
    C12H11NOS2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:25 mg/mL (100.26 mM)
  • SMILES
    CCN1C(=S)S\C(C1=O)=C/c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moorthy B T Ravi S Srivastava M et al. Novel rhodanine derivatives induce growth inhibition followed by apoptosis[J]. Bioorganic and Medicinal Chemistry Letters 2010 20(21):6297-6301.
molnova catalog
related products
  • Etalocib

    Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase.

  • AP-III-a4 hydrochlor...

    AP-III-a4 (ENOblock) hydrochloride is a nonsubstrate analogue enolase inhibitor with an IC50 of 0.576 uM. AP-III-a4 hydrochloride can be used for the research of cancer and diabetic.

  • Pivanex

    Pivanex is an orally active HDAC inhibitor and an antimetastatic and antiangiogenic agent. Pivanex downregulates the Bcr-Abl protein and enhances apoptosis.